| 750548 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P02.05 Comprehensive profiling of tumor heterogeneity and its microenvironment in advanced non-small cell lung cancer at single cell resolution |
2021-10-01 |
10.1136/jitc-2021-itoc8.17 |
Cordts Y, Wu F, Fan J, Odenthal M, Buettner R, Zhou C |
| 750547 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P09.04 Impact of major oncologic surgery on immune responses in the immediate post-operative setting in oesophageal adenocarcinoma patients; a guide to harnessing the double-edged sword of cancer surgery |
2021-10-01 |
10.1136/jitc-2021-itoc8.54 |
Donlon NE, Davern M, Sheppard A, O’Connell F, Ramjit S, Hayes C, Mc Clean M, Temperley H, Butler C, Ravi N, Donohoe C, O’ Sullivan J, Dunne MR, Reynolds JV, Lysaght J |
| 750546 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P06.02 Cancer-specific differences of tertiary lymphoid structures and cellular responses against frequently expressed cancer testis antigens |
2021-10-01 |
10.1136/jitc-2021-itoc8.36 |
Preugszat E, Thelen M, Garcia-Marquez M, Lehmann J, Keller D, von Bergwelt-Baildon M, Schlößer HA |
| 750545 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P02.01 T- and B-cell abundance are remarkably reduced in the immune microenvironment of post-transplant malignancies |
2021-10-01 |
10.1136/jitc-2021-itoc8.13 |
Schran S, Datta R, Persa O, Aguilar C, Thelen M, Lehmann J, Garcia-Marquez M, Wennhold K, Quaas A, Bruns C, Mauch C, Löser H, Stippel D, Schlößer H |
| 750544 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P06.07 In vivo studies of immunomodulatory a-CTLA-4 antibody in a humanized mouse model |
2021-10-01 |
10.1136/jitc-2021-itoc8.41 |
Reitinger C, Nimmerjahn F |
| 750543 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P03.06 Deciphering vaccine-induced neoepitope-specific T cell responses in a patient with H3K27M-mutant midline glioma WHO grade 4 |
2021-10-01 |
10.1136/jitc-2021-itoc8.28 |
Lindner K, Kromer K, Jähne K, Bunse L, Tan C, Poschke I, Green E, Lindner JM, Platten M, Sahm K |
| 750542 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
10.04 A library of novel cancer testis specific T-cell receptors for T-cell receptor gene therapy |
2021-10-01 |
10.1136/jitc-2021-itoc8.4 |
de Rooij MAJ, Steen DM, Remst D, Wouters A, Kester MGD, Hagedoorn RS, van Veelen PA, Verdegaal EME, Falkenburg JHF, Heemskerk MHM |
| 750541 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P04.02 Diversity of CD4+ blood T-cell clonality predicts longer survival with CTLA4 or PD-1 checkpoint inhibition in advanced melanoma |
2021-10-01 |
10.1136/jitc-2021-itoc8.31 |
Arakawa A, Vollmer S, Tietze J, Galinski A, Heppt MV, Berking C, Prinz JC |
| 750540 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Subject index |
2021-10-01 |
10.1136/jitc-2021-itoc8.subjectindex |
|
| 750539 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P07.02 Regulation of CD19 CAR T- cell activation based on engineered Nuclear factor of activated T cells artificial transcription factors |
2021-10-01 |
10.1136/jitc-2021-itoc8.43 |
Lainšček D, Mikolič V, Malenšek Š, Verbič A, Jerala R |
